These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 15231692)
1. Restoration of receptor-type protein tyrosine phosphatase eta function inhibits human pancreatic carcinoma cell growth in vitro and in vivo. Trapasso F; Yendamuri S; Dumon KR; Iuliano R; Cesari R; Feig B; Seto R; Infante L; Ishii H; Vecchione A; During MJ; Croce CM; Fusco A Carcinogenesis; 2004 Nov; 25(11):2107-14. PubMed ID: 15231692 [TBL] [Abstract][Full Text] [Related]
2. An adenovirus carrying the rat protein tyrosine phosphatase eta suppresses the growth of human thyroid carcinoma cell lines in vitro and in vivo. Iuliano R; Trapasso F; Le Pera I; Schepis F; Samà I; Clodomiro A; Dumon KR; Santoro M; Chiariotti L; Viglietto G; Fusco A Cancer Res; 2003 Feb; 63(4):882-6. PubMed ID: 12591742 [TBL] [Abstract][Full Text] [Related]
3. Thyroid cell transformation inhibits the expression of a novel rat protein tyrosine phosphatase. Zhang L; Martelli ML; Battaglia C; Trapasso F; Tramontano D; Viglietto G; Porcellini A; Santoro M; Fusco A Exp Cell Res; 1997 Aug; 235(1):62-70. PubMed ID: 9281353 [TBL] [Abstract][Full Text] [Related]
4. Rat protein tyrosine phosphatase eta suppresses the neoplastic phenotype of retrovirally transformed thyroid cells through the stabilization of p27(Kip1). Trapasso F; Iuliano R; Boccia A; Stella A; Visconti R; Bruni P; Baldassarre G; Santoro M; Viglietto G; Fusco A Mol Cell Biol; 2000 Dec; 20(24):9236-46. PubMed ID: 11094075 [TBL] [Abstract][Full Text] [Related]
6. The protein tyrosine phosphatase DEP-1 is induced during differentiation and inhibits growth of breast cancer cells. Keane MM; Lowrey GA; Ettenberg SA; Dayton MA; Lipkowitz S Cancer Res; 1996 Sep; 56(18):4236-43. PubMed ID: 8797598 [TBL] [Abstract][Full Text] [Related]
7. Potential tumor suppressive pathway involving DUSP6/MKP-3 in pancreatic cancer. Furukawa T; Sunamura M; Motoi F; Matsuno S; Horii A Am J Pathol; 2003 Jun; 162(6):1807-15. PubMed ID: 12759238 [TBL] [Abstract][Full Text] [Related]
8. Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function. Schniewind B; Groth S; Sebens Müerköster S; Sipos B; Schäfer H; Kalthoff H; Fändrich F; Ungefroren H Oncogene; 2007 Jul; 26(33):4850-62. PubMed ID: 17297450 [TBL] [Abstract][Full Text] [Related]
9. The phosphotyrosine phosphatase eta mediates somatostatin inhibition of glioma proliferation via the dephosphorylation of ERK1/2. Massa A; Barbieri F; Aiello C; Iuliano R; Arena S; Pattarozzi A; Corsaro A; Villa V; Fusco A; Zona G; Spaziante R; Schettini G; Florio T Ann N Y Acad Sci; 2004 Dec; 1030():264-74. PubMed ID: 15659806 [TBL] [Abstract][Full Text] [Related]
10. An extracellular ligand increases the specific activity of the receptor-like protein tyrosine phosphatase DEP-1. Sörby M; Sandström J; Ostman A Oncogene; 2001 Aug; 20(37):5219-24. PubMed ID: 11526512 [TBL] [Abstract][Full Text] [Related]
11. RNA interference targeting protein tyrosine phosphatase zeta/receptor-type protein tyrosine phosphatase beta suppresses glioblastoma growth in vitro and in vivo. Ulbricht U; Eckerich C; Fillbrandt R; Westphal M; Lamszus K J Neurochem; 2006 Sep; 98(5):1497-506. PubMed ID: 16923162 [TBL] [Abstract][Full Text] [Related]
12. Genetic characterization of fas-associated phosphatase-1 as a putative tumor suppressor gene on chromosome 4q21.3 in hepatocellular carcinoma. Yeh SH; Wu DC; Tsai CY; Kuo TJ; Yu WC; Chang YS; Chen CL; Chang CF; Chen DS; Chen PJ Clin Cancer Res; 2006 Feb; 12(4):1097-108. PubMed ID: 16489062 [TBL] [Abstract][Full Text] [Related]
13. HD-PTP: A novel protein tyrosine phosphatase gene on human chromosome 3p21.3. Toyooka S; Ouchida M; Jitsumori Y; Tsukuda K; Sakai A; Nakamura A; Shimizu N; Shimizu K Biochem Biophys Res Commun; 2000 Nov; 278(3):671-8. PubMed ID: 11095967 [TBL] [Abstract][Full Text] [Related]
14. Identification of the retinoic acid-inducible Gprc5a as a new lung tumor suppressor gene. Tao Q; Fujimoto J; Men T; Ye X; Deng J; Lacroix L; Clifford JL; Mao L; Van Pelt CS; Lee JJ; Lotan D; Lotan R J Natl Cancer Inst; 2007 Nov; 99(22):1668-82. PubMed ID: 18000218 [TBL] [Abstract][Full Text] [Related]
15. Effect of recombinant adenovirus vector mediated human interleukin-24 gene transfection on pancreatic carcinoma growth. Pan XT; Zhu QY; Li DC; Yang JC; Zhang ZX; Zhu XG; Zhao H Chin Med J (Engl); 2008 Oct; 121(20):2031-6. PubMed ID: 19080270 [TBL] [Abstract][Full Text] [Related]
16. Tumor growth suppression by adenovirus-mediated introduction of a cell-growth-suppressing gene tob in a pancreatic cancer model. Yanagie H; Tanabe T; Sumimoto H; Sugiyama H; Matsuda S; Nonaka Y; Ogiwara N; Sasaki K; Tani K; Takamoto S; Takahashi H; Eriguchi M Biomed Pharmacother; 2009 May; 63(4):275-86. PubMed ID: 18657378 [TBL] [Abstract][Full Text] [Related]
17. [The activation of the phosphotyrosine phosphatase eta is responsible for the somatostatin inhibition of PCCl3 thyroid cell proliferation]. Florio T; Arena S; Thellung S; Iuliano R; Corsaro A; Massa A; Villa V; Pattarozzi A; Diana F; Fusco A; Schettini G Minerva Endocrinol; 2001 Dec; 26(4):277-83. PubMed ID: 11782716 [TBL] [Abstract][Full Text] [Related]
18. Functional analysis of a cell cycle-associated, tumor-suppressive gene, protein tyrosine phosphatase receptor type G, in nasopharyngeal carcinoma. Cheung AK; Lung HL; Hung SC; Law EW; Cheng Y; Yau WL; Bangarusamy DK; Miller LD; Liu ET; Shao JY; Kou CW; Chua D; Zabarovsky ER; Tsao SW; Stanbridge EJ; Lung ML Cancer Res; 2008 Oct; 68(19):8137-45. PubMed ID: 18829573 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of human bladder tumour cell growth by fibroblast growth factor receptor 2b is independent of its kinase activity. Involvement of the carboxy-terminal region of the receptor. Bernard-Pierrot I; Ricol D; Cassidy A; Graham A; Elvin P; Caillault A; Lair S; Broët P; Thiery JP; Radvanyi F Oncogene; 2004 Dec; 23(57):9201-11. PubMed ID: 15516981 [TBL] [Abstract][Full Text] [Related]
20. Catalase reverses tumorigenicity in a malignant cell line by an epidermal growth factor receptor pathway. Finch JS; Tome ME; Kwei KA; Bowden GT Free Radic Biol Med; 2006 Mar; 40(5):863-75. PubMed ID: 16520238 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]